Answers are grounded in this paper and cite their sources.
Study reveals Truncated APC dampens innate immune response in colorectal cancer, suggesting epigenetic therapy may improve outcomes.
Our study reveals a previously unrecognized role of Trunc-APC in dampening tumor-intrinsic innate immunity and suggests that co-targeting Trunc-APC with epigenetic therapy may offer a promising strategy to enhance anti-tumor immune responses in CRC.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: